dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(((ethyne-1,2-diylbis(3,1-phenylene))bis(azanediyl))bis(carbonyl))bis(pyrrolidine-2,1-diyl))bis(4-(methylthio)-1-oxobutane-2,1-diyl))dicarbamate

ID: ALA5187679

Chembl Id: CHEMBL5187679

PubChem CID: 168279667

Max Phase: Preclinical

Molecular Formula: C38H48N6O8S2

Molecular Weight: 780.97

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)Nc1cccc(C#Cc2cccc(NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCSC)NC(=O)OC)c2)c1

Standard InChI:  InChI=1S/C38H48N6O8S2/c1-51-37(49)41-29(17-21-53-3)35(47)43-19-7-13-31(43)33(45)39-27-11-5-9-25(23-27)15-16-26-10-6-12-28(24-26)40-34(46)32-14-8-20-44(32)36(48)30(18-22-54-4)42-38(50)52-2/h5-6,9-12,23-24,29-32H,7-8,13-14,17-22H2,1-4H3,(H,39,45)(H,40,46)(H,41,49)(H,42,50)/t29-,30-,31-,32-/m0/s1

Standard InChI Key:  WKCDLSFRXMMOOA-YDPTYEFTSA-N

Alternative Forms

  1. Parent:

    ALA5187679

    ---

Associated Targets(Human)

Huh-5-2 (386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 780.97Molecular Weight (Monoisotopic): 780.2975AlogP: 3.90#Rotatable Bonds: 14
Polar Surface Area: 175.48Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.58CX Basic pKa: CX LogP: 3.51CX LogD: 3.51
Aromatic Rings: 2Heavy Atoms: 54QED Weighted: 0.21Np Likeness Score: -0.77

References

1. Abdallah M, Hamed MM, Frakolaki E, Katsamakas S, Vassilaki N, Bartenschlager R, Zoidis G, Hirsch AKH, Abdel-Halim M, Abadi AH..  (2022)  Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrier.,  229  [PMID:34959173] [10.1016/j.ejmech.2021.114034]

Source